Table 2.

Characteristics of pre implant MCS recipients with and without EQ-5D-3L data

Pre-Implant Characteristics	Pre implant MCS recipients who completed the EQ-5D n=1190*	Pre implant MCS recipients who did not complete the EQ-5Dn=369	p-value
Demographic and behavioral characteristics
Age at implant (mean years)	53.48	54.11	0.39
Male (%)	77.2	80.5	0.19
Race (% white)	69.4	65.9	0.20
Married at time of implant (%)	62.3	62.3	1.00
> high school education (%)	52.6	53.5	0.79
Currently smoking (%)	13.2	12.0	0.59
Current alcohol abuse (%)	15.2	18.3	0.16
Current drug abuse (%)	2.5	3.0	0.66
Clinical characteristics
Primary cardiac diagnosis (%)
Ischemic cardiomyopathy	36.1	35.0	0.68
Dilated cardiomyopathy	49.7	56.8	0.04
Other	14.2	9.2	0.01
Co-morbidities (%)
Diabetes	37.9	40.1	0.46
CVA	8.1	5.3	0.08
Right heart failure (RVEF severe)	24.3	26.3	0.60
Pre COPD	12.6	14.8	0.30
NYHA class IV (%)	79.6	71.1	0.0014
Intra aortic balloon pump (%)	36.0	31.2	0.09
Ventilator (%)	9.7	4.1	0.0007
ECMO	2.4	1.4	0.21
Dialysis	2.1	2.7	0.49
INTERMACS profile at implant (%)
1	18.5	11.4	0.0014
2	45.9	40.4	0.06
3	19.8	25.5	0.02
4	10.7	13.0	0.21
5	2.4	4.6	0.03
6	1.7	3.0	0.12
7	1.0	2.2	0.0002
Device strategy (%)
Bridge to transplant –listed	46.8	48.0	0.70
Bridge to transplant –likely to be listed	30.5	33.1	0.35
Bridge to transplant –moderately likely to be listed	9.9	9.2	0.69
Bridge to transplant –unlikely to be listed	3.4	2.2	0.25
Destination therapy	7.9	6.5	0.38
Inotrope therapy (%)	83.6	74.8	0.0002
Implantable cardioverter defibrillator (%)	78.7	83.0	0.07
Temporary circulatory support (%)	12.9	11.6	0.56

MCS = mechanical circulatory support, CAD = coronary artery disease, CVA = cerebrovascular accident, COPD = chronic obstructive pulmonary disease, ECMO = extracorporeal membrane oxygenation

^*Those patients who were ‘too sick’ have been included in the ‘completed’ column and assigned VAS=0 and physical dimensions as ‘extreme problems’ (i.e., group 1)